MOH
Molina Healthcare, Inc.
MOH's outlook is improving, though it still trails on the overall score.
UNH
UnitedHealth Group Incorporated
UNH has the edge over MOH overall, supported by lower modeled downside and stronger modeled upside.
MOH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Stable | |
| Strong |
MOH's balance sheet is currently strong, and its revenue and cash flow are stable, but its profitability is under pressure.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
MOH PE Valuation
MOH has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
MOH Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for MOH, with profitability holding steady. However, they disagree widely on these estimates.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
MOH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $8.35 | — |
| Q3 2026 | -$0.60 | -104% |
| Q2 2026 | $0.18 | -99% |
| Q1 2026 | $3.74 | -82% |
| Q4 2025 | $8.92 | -56% |
| Q3 2025 | $16.14 | -18% |
| Q2 2025 | $20.28 | +11% |
| Q1 2025 | $20.70 | +12% |
| Q4 2024 | $20.42 | +8.8% |
MOH has swung to a loss: it lost $0.60 per share over the past year, after a profit the year before.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH has the edge over MOH on earnings quality, reporting a profit while its opponent remains loss making.
MOH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11.1B | -3.4% |
| Q2 2026 | $10.9B | -4.8% |
| Q1 2026 | $10.8B | -3.1% |
| Q4 2025 | $11.4B | +8.3% |
| Q3 2025 | $11.5B | +11% |
| Q2 2025 | $11.4B | +16% |
| Q1 2025 | $11.1B | +12% |
| Q4 2024 | $10.5B | +16% |
MOH's revenue grew through 2024 and has held roughly level since: $11.1B last quarter, down 3.4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1% | -0.2 points |
| Q2 2026 | 1.3% | -1.9 points |
| Q1 2026 | 0.8% | -3.1 points |
| Q4 2025 | -1.4% | -5 points |
| Q3 2025 | 1.2% | -3.3 points |
| Q2 2025 | 3.3% | -1.1 points |
| Q1 2025 | 3.9% | -0.4 points |
| Q4 2024 | 3.6% | +0.1 points |
MOH's operating margin was 1% last quarter, about level with the same quarter a year ago, near the bottom of its range since 2019.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH's revenue has held roughly level: $113B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH has the edge over MOH on profitability, with a higher operating margin.
MOH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$196M | -$33M |
| Q2 2026 | -$324M | +$20M |
| Q1 2026 | $1.1B | +528% |
| Q4 2025 | -$297M | -$62M |
| Q3 2025 | -$163M | -119% |
| Q2 2025 | -$344M | -$98M |
| Q1 2025 | $168M | -10% |
| Q4 2024 | -$235M | +$450M |
MOH's free cash flow has turned positive after two years mostly in the red: $238M over the past year.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over MOH on cash flow, with more consistent year-over-year improvement.
MOH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +200K shares |
| 1 year | -1.9% | -1M shares |
| 3 years | -11% | -6.6M shares |
| 5 years | -12% | -7M shares |
| Available history | -20% | -12.7M shares |
MOH has the edge over UNH on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $500M |
| Q2 2025 | — |
| Q1 2025 | $500M |
| Q4 2024 | $500M |
MOH hasn't bought back shares in the past year.
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has 902M diluted shares, down 0.7% from a year ago, with $5B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
MOH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -2.1x | Net Cash |
| Q2 2026 | -3.3x | Net Cash |
| Q1 2026 | -2.5x | Net Cash |
| Q4 2025 | -0.5x | Net Cash |
| Q3 2025 | -0.4x | Net Cash |
| Q2 2025 | -0.6x | Net Cash |
| Q1 2025 | -0.7x | Net Cash |
| Q4 2024 | -0.9x | Net Cash |
MOH has the edge over UNH on leverage, with a lower net debt burden relative to earnings.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
MOH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 55.8 | Neutral |
MOH's weekly RSI is 56 (neutral) and its Stochastic is 56 (neutral).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
MOH PE vs Healthcare Sector
| Metric | MOH | Sector median | Relative |
|---|---|---|---|
| PE | 1,152x | 26x | 4,356% above |
| PE % | 100 | 29 | 71 pts above |
MOH has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH has the edge over MOH on valuation relative to its sector.
MOH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $202.2 | 3.8% above |
| 20 week MA | $205.7 | 2% above |
| 50 week MA | $183.7 | 14% above |
| 100 week MA | $216.0 | 2.9% below |
| 200 week MA | $271.6 | 23% below |
MOH has bounced recently, but its long-term trend is still down: it's above its 8-, 20- and 50-week averages, but 23% below its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over MOH on trend strength, trading above more of its moving averages.
MOH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $136.1 | $207.1 | +52% |
| 2021 | $207.1 | $316.7 | +53% |
| 2022 | $316.7 | $335.1 | +5.8% |
| 2023 | $335.1 | $361.3 | +7.8% |
| 2024 | $361.3 | $292.2 | -19% |
| 2025 | $292.2 | $164.8 | -44% |
| 2026 YTD | $164.8 | $209.9 | +27% |
MOH has the edge over UNH on returns for 2026, with the stronger performance.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has finished three years in a row lower, and it's up 22% so far in 2026.